Literature DB >> 3158261

Drug extravasation as a complication of venous access ports.

W P Reed, K A Newman, M M Applefeld, F J Sutton.   

Abstract

Mesh：

Substances：

Year:  1985        PMID： 3158261     DOI： 10.7326/0003-4819-102-6-788

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  4 in total

1.  [A totally implantable permanent central venous access, long-term experience with subcutaneous infusion chambers].

Authors:  M Lorenz; C Hottenrott; R M Seufert; A Encke
Journal:  Langenbecks Arch Chir       Date:  1988

Review 2.  Continuous infusion of low-dose doxorubicin, epirubicin and mitoxantrone in cancer chemotherapy: a review.

Authors:  J Greidanus; P H Willemse; D R Uges; E T Oremus; Z J De Langen; E G De Vries
Journal:  Pharm Weekbl Sci       Date:  1988-12-09

3.  Clinical evaluation of the CORDIS vascular access port systems: a multicenter study.

Authors:  A Hoekstra; V Bassot; S Bertoglio; J Y Bobin; P Delassus; R Egeli; D Khayat; J Y Ranchere; J Santini; P Segol
Journal:  Med Oncol Tumor Pharmacother       Date:  1993

4.  Comparison between peripherally implanted ports and externally sited catheters for long-term venous access.

Authors:  A M Pullyblank; P D Carey; S Z Pearce; A G Tanner; P J Guillou; J R Monson
Journal:  Ann R Coll Surg Engl       Date:  1994-01       Impact factor: 1.891
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.